The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Alpelisib (ALP) + endocrine therapy (ET) in patients (pts) with PIK3CA-mutated hormone receptor-positive (HR+), human epidermal growth factor-2-negative (HER2-) advanced breast cancer (ABC): First interim BYLieve study results.
 
Hope S. Rugo
Research Funding - Daiichi Sankyo (Inst); Eisai (Inst); Genentech (Inst); Immunomedics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Amgen; Mylan; Novartis; OBI Pharma; Pfizer; Puma Biotechnology; Roche/Genentech; Sanofi
 
Manuel Ruiz Borrego
No Relationships to Disclose
 
Stephen K. L. Chia
Honoraria - Genomic Health; Novartis
Consulting or Advisory Role - Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Genentech (Inst); Genomic Health (Inst); Novartis (Inst); Roche (Inst)
 
Dejan Juric
Consulting or Advisory Role - Eisai; EMD Serono; Genentech; Ipsen; Novartis
Research Funding - Eisai; EMD Serono; Genentech; Novartis; Placon; Takeda
 
Nicholas C. Turner
Consulting or Advisory Role - AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Tesaro
Research Funding - AstraZeneca (Inst); Bio-Rad (Inst); Clovis Oncology (Inst); Guardant Health (Inst); Pfizer (Inst); Roche (Inst)
 
Pamela Drullinsky
No Relationships to Disclose
 
Florence Lerebours
Honoraria - AstraZeneca; Lilly
Consulting or Advisory Role - AstraZeneca; Eisai
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Novartis
 
Giulia Valeria Bianchi
No Relationships to Disclose
 
Carolyn C. Nienstedt
Employment - Novartis
 
Antonia Ridolfi
Employment - Novartis
 
Astrid Thuerigen
Employment - Novartis; Pierre Fabre
Stock and Other Ownership Interests - Novartis
 
Eva Ciruelos
Honoraria - Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer; Roche